Biperiden
Brand names: AKINETON
Therapeutic Indications
Biperiden is indicated for:
Nicotine poisoning
No gender/age discrimination
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intramuscular - 5-10 mg
Treatment 2: Intravenous - 5-10 mg
Drug-related extrapyramidal symptoms
Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 1-3mg daily
Treatment 2: Oral - 1-2mg 1-3 times daily
Treatment 3: Intramuscular - 1-3mg daily
Poisoning by organic phosphorous compounds
Irrespective of gender only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 5 mg
Parkinsonism
Irrespective of gender only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intramuscular - 10-20 mg daily
Treatment 2: Oral - 1-8 mg twice a day
Treatment 3: Intravenous - 10-20 mg daily
Drug-related extrapyramidal symptoms
Irrespective of gender only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intramuscular - 2.5-20 mg daily
Treatment 2: Oral - 1-2mg 2–3 times daily
Treatment 3: Intravenous - 2.5-20 mg daily
Contraindications
Active ingredient Biperiden is contraindicated in the following cases:
Megacolon
No gender/age discrimination
Untreated narrow angle glaucoma
No gender/age discrimination
Mechanical stenoses in the gastro-intestinal tract
No gender/age discrimination